大洋生物：9月12日召开董事会会议

Group 1 - The company, Dayang Bio (SZ 003017), held its sixth board meeting on September 12, 2025, to review various proposals, including the confirmation of the audit committee members and the convener [1] - For the first half of 2025, the company's revenue composition was 95.72% from the chemical industry and 4.28% from other sources [1] - As of the report date, Dayang Bio's market capitalization was 2.8 billion yuan [1]